Enterprise Value:
$4.85B-$169.17M(-3.37%)Summary
- As of today, CRSP enterprise value is $4.85 billion, with a fall of -$169.17 million (-3.37%) during the current trading session.
- Over the past year, CRSP enterprise value has increased by +$2.38 billion (+96.24%).
- CRSP enterprise value is now -65.07% below its all-time high of $13.90 billion.
Performance
CRSP Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CRSP Enterprise Value Trends
PeriodPeriod | Enterprise ValueEnterprise Value | Market CapMarket Cap | PricePrice |
---|---|---|---|
1D1 Day | -3.4% | -2.6% | -2.6% |
1M1 Month | +19.7% | +14.3% | +14.3% |
3M3 Months | +44.3% | +30.6% | +26.9% |
6M6 Months | +199.0% | +95.0% | +85.2% |
YTDYTD | +186.4% | +88.5% | +77.7% |
1Y1 Year | +96.2% | +52.2% | +42.8% |
5Y5 Years | -24.6% | -17.9% | -36.3% |
CRSP Enterprise Value Highs & Lows
PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
---|---|---|---|---|---|
1M | 1-Month | $5.47B | -11.3% | $3.75B | +29.4% |
3M | 3-Month | $5.47B | -11.3% | $3.15B | +54.0% |
6M | 6-Month | $5.47B | -11.3% | $1.22B | +296.4% |
1Y | 1-Year | $5.47B | -11.3% | $1.06B | +357.4% |
3Y | 3-Year | $6.05B | -19.8% | $1.06B | +357.4% |
5Y | 5-Year | $13.90B | -65.1% | $1.06B | +357.4% |
All-Time | All-Time | $13.90B | -65.1% | $256M | +1796.7% |
CRSP Enterprise Value History
Date | Value |
---|---|
2025 | $4.85B(+186.4%) |
2024 | $1.69B(-52.3%) |
2023 | $3.56B(+119.5%) |
2022 | $1.62B(-56.0%) |
2021 | $3.68B(-62.0%) |
Date | Value |
---|---|
2020 | $9.69B(+244.7%) |
2019 | $2.81B(+174.3%) |
2018 | $1.02B(+43.7%) |
2017 | $713.35M(+45.8%) |
2016 | $489.20M |
FAQ
- What is CRISPR Therapeutics AG enterprise value?
- What is the all-time high enterprise value for CRISPR Therapeutics AG?
- What is CRSP enterprise value year-to-date change?
- What is CRISPR Therapeutics AG enterprise value year-on-year change?
What is CRISPR Therapeutics AG enterprise value?
The current enterprise value of CRSP is $4.85B
What is the all-time high enterprise value for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high enterprise value is $13.90B
What is CRSP enterprise value year-to-date change?
CRISPR Therapeutics AG enterprise value has changed by +$3.16B (+186.40%) since the beginning of the year
What is CRISPR Therapeutics AG enterprise value year-on-year change?
Over the past year, CRSP enterprise value has changed by +$2.38B (+96.24%)